ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
C

EHA 2022 CARTBCMA-HCB-01 Study Updates: A Novel CAR T-Cell Therapy Targeting BCMA Is Highly Effective for R/R MM

By ecancer FEATURING Carlos Fernandez De Larrea
By ecancer FEATURING Carlos Fernandez De Larrea
105 views
June 21, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley
EHA 2022
04:46

Phase II Expansion Results: Glofitamab Induces Durable Complete Remi…

ecancer

M. Dickinson

21 views
03:35

EHA 2022: Quizartinib Improves OS in Adults With FLT3-ITD+ AML

ecancer

H. Erba

32 views
06:01

EHA 2022: Ponatinib & Blinatumomab for Patients With Ph+ ALL

ecancer

N. Short

149 views
07:31

EHA 2022 on CLIMB THAL-111 and CLIMB SCD-121 Studies: Single-Dose ct…

ecancer

F. Locatelli

22 views
03:54

EHA 2022 on a Bispecific Antibody Talquetamab in R/R MM: Safety & Ef…

ecancer

M. Minnema

25 views
05:24

EHA 2022 CARTBCMA-HCB-01 Study Updates: A Novel CAR T-Cell Therapy T…

ecancer

C. Fernandez De Larrea

105 views
03:44

EHA 2022 on R-CODOX-M/R-IVAC vs. Dose-Adjusted EPOCH-R in Newly Diag…

ecancer

M. Chamuleau

25 views
04:51

EHA 2022 on Targeted Therapy Combinations With Venetoclax Superior t…

ecancer

B. Eichhorst

97 views
04:29

EHA 2022 Time-Limited Venetoclax-Obinutuzumab +/- Ibrutinib Surpasse…

ecancer

B. Eichhorst

244 views
03:35

EHA 2022 on the Efficacy & Safety of ARI0002H, a BCMA-Directed CAR T…

ecancer

C. Fernandez De Larrea

8 views
04:29

EHA 2022 on a Phase III GMMG-HD7 Trial: Isa-RVd as Induction Therapy…

ecancer

E. Mai

100 views
02:19

Lecture Summary - EHA 2022: Lenalidomide, Bortezomib, and Dexamethas…

ecancer

P. Richardson